Skip to main content
Premium Trial:

Request an Annual Quote

Fitch Affirms BBB+ Ratings for Agilent

NEW YORK (GenomeWeb News) – Fitch Ratings late on Tuesday affirmed several ratings of BBB+ for Agilent Technologies.

The BBB+ ratings, which translate to good credit quality, were affirmed for Agilent's Issuer Default Rating, senior unsecured revolving credit facility, and senior unsecured notes. Fitch's actions affect about $2.6 billion of debt, including an undrawn $400 million revolving credit facility that expires in 2016, Fitch said.

It rated Agilent's outlook Stable.

Fitch noted Agilent's strengthened operating profile and continued diversification of its revenue mix, saying that though the Electronics Measurement Group still makes up about half of Agilent's total revenues and "well over half" of its operating income, faster and stable organic growth in markets served by the Life Sciences Group and Chemical Analysis Group "should tip this balance over the intermediate term."

It added that acquisitions are more likely in the Life Sciences and Chemical Analysis businesses, which would accelerate the portfolio shift, and noted the $1.5 billion Varian acquisition completed about two years ago, which added about $700 million in annual revenues to Chemical Analysis Group, and a little less than that to Life Sciences.

"Nonetheless, future acquisitions likely will be smaller in size and focused on technologies that can be leveraged by Agilent's global footprint," Fitch said in a statement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.